Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Summer;7(2):e151-e157.
doi: 10.1016/j.ddmec.2010.09.009.

Fixing ryanodine receptor Ca leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle

Affiliations

Fixing ryanodine receptor Ca leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle

Daniel C Andersson et al. Drug Discov Today Dis Mech. 2010 Summer.

Abstract

A critical component in regulating cardiac and skeletal muscle contractility is the release of Ca(2+) via ryanodine receptor (RyR) Ca(2+) release channels in the sarcoplasmic reticulum (SR). In heart failure and myopathy, the RyR has been found to be excessively phosphorylated or nitrosylated and depleted of the RyR-stabilizing protein calstabin (FK506 binding protein 12/12.6). This remodeling of the RyR channel complex results in an intracellular SR Ca(2+) leak and impaired contractility. Despite recent advances in heart failure treatment, there are still devastatingly high mortality rates with this disease. Moreover, pharmacological treatment for muscle weakness and myopathy is nearly nonexistent. A novel class of RyR-stabilizing drugs, rycals, which reduce Ca(2+) leak by stabilizing the RyR channels due to preservation of the RyR-calstabin interaction, have recently been shown to improve contractile function in both heart and skeletal muscle. This opens up a novel therapeutic strategy for the treatment of contractile failure in the cardiac and skeletal muscle.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: A.R. Marks is a consultant for a start-up company, ARMGO Pharma Inc., that is targeting RyR channels to treat heart disease and to improve exercise capacity in muscle diseases

Figures

Figure 1
Figure 1. Excitation-contraction coupling in cardiac and skeletal muscle
A) Figure showing the principals of Ca2+ cycling in excitation-contraction (E-C) coupling of the cardiomyocyte. Upon depolarization of the sarcolemma, L-type Ca2+ channels open to allow Ca2+ to enter the cell. This Ca2+ will in turn activate the juxtaposed RyR and more Ca2+ will be released. The bulk of cytoplasmic [Ca2+] increase is due to RyR-mediated release of Ca2+ from the SR. Cytoplasmic Ca2+ will trigger myofilament activity so that contraction can occur. To relax, cytoplasmic Ca2+ is pumped back into the SR via the SR Ca2+ ATPase (SERCA2a) and extruded out of the cell through the sarcolemmal Na+-Ca2+ exchanger (NCX). B) Depicts Ca2+ handling in skeletal muscle E-C coupling. L-type Ca2+ channels at the sarcolemma and RyR1 in the SR membrane are in close vicinity with each other. Depolarization of the sarcolemma causes the L-type Ca2+ channel to interact with and activate the RyR independent of entry of extracellular Ca2+. Virtually all of the increase in cytoplasmic [Ca2+] that is needed for myofilament activation and force generation comes from SR Ca2+ release. The Ca2+ is cleared from the cytoplasm via the SERCA. The absence of transsarcolemmal Ca2+ fluxes underscores the importance of RyR1 Ca2+ release function in skeletal muscle ECC.
Figure 1
Figure 1. Excitation-contraction coupling in cardiac and skeletal muscle
A) Figure showing the principals of Ca2+ cycling in excitation-contraction (E-C) coupling of the cardiomyocyte. Upon depolarization of the sarcolemma, L-type Ca2+ channels open to allow Ca2+ to enter the cell. This Ca2+ will in turn activate the juxtaposed RyR and more Ca2+ will be released. The bulk of cytoplasmic [Ca2+] increase is due to RyR-mediated release of Ca2+ from the SR. Cytoplasmic Ca2+ will trigger myofilament activity so that contraction can occur. To relax, cytoplasmic Ca2+ is pumped back into the SR via the SR Ca2+ ATPase (SERCA2a) and extruded out of the cell through the sarcolemmal Na+-Ca2+ exchanger (NCX). B) Depicts Ca2+ handling in skeletal muscle E-C coupling. L-type Ca2+ channels at the sarcolemma and RyR1 in the SR membrane are in close vicinity with each other. Depolarization of the sarcolemma causes the L-type Ca2+ channel to interact with and activate the RyR independent of entry of extracellular Ca2+. Virtually all of the increase in cytoplasmic [Ca2+] that is needed for myofilament activation and force generation comes from SR Ca2+ release. The Ca2+ is cleared from the cytoplasm via the SERCA. The absence of transsarcolemmal Ca2+ fluxes underscores the importance of RyR1 Ca2+ release function in skeletal muscle ECC.
Figure 2
Figure 2. Dissociation of calstabin (FKBP12/FKBP12.6) from the RyR macromolecular complex underlies SR Ca2+ leak. A–B)
Under normal conditions, the interaction between calstabin and the RyR subunits stabilize the channel function and minimizes SR Ca2+ leak when the cell is in resting condition(A). B) Upon activation of the RyR (e.g. by increased [Ca2+]or via interaction with the DHPR), the channel opens and Ca2+ is released from the sarcoplasmic reticulum (SR) into the cytosol, driven by the large SR-cytosolic concentration gradient. C–D) The RyR is a target for stress signals (e.g. β-adrenergic receptor-mediated PKA-dependent phosphorylation of serine residues, nitrosylation of cysteines and oxidative modifications of the RyR). Chronic stress signaling can lead to dissociation of calstabin from the Ca2+ release channel that then becomes leaky, Ca2+ oozes out through the channel and the SR Ca2+ load is diminished (C). Under such conditions, the driving force for Ca2+ across the SR membrane is reduced and upon activation of the RyR less Ca2+ will be released to the cytosol.

References

    1. Cowie MR, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000;83 (5):505–510. - PMC - PubMed
    1. Farr MA, Basson CT. Sparking the failing heart. N Engl J Med. 2004;351 (2):185–187. - PubMed
    1. Lloyd-Jones D, et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 121(7):e46–e215. - PubMed
    1. Bellinger AM, et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med. 2009;15 (3):325–330. - PMC - PubMed
    1. Marx SO, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101 (4):365–376. - PubMed

LinkOut - more resources